Immodulon appoints new CSO Immodulon appoints new CSO Effective immediately Thomas Kleen will take on the role within the senior management team Dr William F Feehery is new Certara CEO Dr William F Feehery is new Certara CEO Effective 3 June, Dr William F Feehery will take over the model-informed drug development services company Prudential family leadership goes to third generation Prudential family leadership goes to third generation John Clark, son of departing CEO, Dan Clark, and third generation family member, will assume the CEO position Asceneuron appoints new Board Member Asceneuron appoints new Board Member Dr Eric Yuen will join the company and help initiate later stage clinical development in the tau pathology space Mogrify appoints new CBO and COO Mogrify appoints new CBO and COO New executives at the biopharma company will be Dr Karin Schmitt as Chief Business Officer and Joe Foster as Chief Operating Officer Almac Group appoints Dr Sheryl Foster as Vice President of Quality Almac Group appoints Dr Sheryl Foster as Vice President of Quality Metrion Biosciences appoints new CEO Metrion Biosciences appoints new CEO The promotion of Dr Andrew Southan from COO is effective immediately PCI Pharma Services announces organisation updates PCI Pharma Services announces organisation updates Scancell establishes clinical advisory board Scancell establishes clinical advisory board Board will provide the necessary guidance as cancer immunotherapy company prepares for its lead Moditope candidate to enter the clinic in 2020 Evox hires two experienced new VPs Evox hires two experienced new VPs Bo Kara will take over VP of Process Development and Simon Dew will be VP of Business Development ABPI names Novartis MD Haseeb Ahmad as President ABPI names Novartis MD Haseeb Ahmad as President New Midlands account manager appointed at Burkert New Midlands account manager appointed at Burkert Nanoform strengthens GMP capabilities with Head of Manufacturing appointment Nanoform strengthens GMP capabilities with Head of Manufacturing appointment Dr Mathew Minardi joins Sterling Pharma Solutions Dr Mathew Minardi joins Sterling Pharma Solutions Stuart Ashman joins SkinBioTherapeutics Stuart Ashman joins SkinBioTherapeutics Pierre Fabre names new pharma CEO Pierre Fabre names new pharma CEO Jean-Luc Lowinski, a former Sanofi executive, spearheads Pierre Fabre Pharmaceuticals Biopharma names new Group Sales Director Biopharma names new Group Sales Director Dr Roberto Castangia has taken the baton from Peter Williams who has chosen to retire, effective June 2019 GEA makes key appointments GEA makes key appointments Parker Bioscience Filtrations appoints new general manager of UK site Parker Bioscience Filtrations appoints new general manager of UK site Kris Holmes will take up the role and help drive growth in the EMEA region Dr Frederick Hausheer joins WuXi AppTec to lead cancer drug development Dr Frederick Hausheer joins WuXi AppTec to lead cancer drug development Chinese pharma giant has appointed Dr Hausheer as Chief Medical Officer Oxford BioDynamics appoints new President for US subsidiary Oxford BioDynamics appoints new President for US subsidiary Glen Ferguson has been made Senior VP of US at the parent company, but has also been appointed as the President of the new US subsidiary Mologic expands US and UK operations Mologic expands US and UK operations The UK-based company that develops lateral flow and rapid diagnostic technologies has made multiple appointments in order to bolster US presence New Managing Director Sales at Uhlmann New Managing Director Sales at Uhlmann Michael Mrachacz succeeds Siegfried Drost PCI Pharma Services appoints new SVP and CFO PCI Pharma Services appoints new SVP and CFO